Abbott Laboratories plans spinout of its global nutrition business

Abbott Laboratories announced plans to spin off its nutrition business into an independent public company, Food Dive reported. The division produces commercial brands including Ensure and Pedialyte. Company executives said the separation will allow the new standalone entity to better capitalize on growing demand for functional and healthy nutrition. [1][2]

Abbott chief executive officer Robert Ford said the separation would allow both companies to maximize success in their respective sectors, according to Food Dive. The corporate restructuring will permit the remaining parent business to concentrate resources on higher-growth markets. [1]

Abbott is an American multinational medical devices and healthcare company headquartered in Abbott Park, Illinois, near Chicago. Beyond nutritional products, the parent firm manufactures diagnostic systems, medical equipment, and international pharmaceuticals. [2]

The transaction aligns Abbott with broader corporate strategies across the medical technology sector, Food Dive reported. Medtronic completed a similar separation of its diabetes division earlier this year, while Johnson and Johnson plans to spin out its orthopedics business. [1]